Medtech contract manufacturing giant Integer saw its stock rise more than 7% today on Street-busting second-quarter results. Plano, Texas–based Integer earned nearly $24 million, or 71¢ per share, off of $400 million in revenue for the quarter that ended June 30, 2023. The bottom line was up 15%, and the top line rose 14% compared […]
integer
Integer stock down on Q4 prelims, convertible notes plans
Integer Holdings (NYSE: ITGR) stock is down — a day after the medtech contract manufacturing giant released preliminary fourth-quarter numbers. ITGR shares were down more than 7% to $65.30 apiece by midday today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was up more than 9%. Plano, Texas–based Integer […]
Integer Q3 results mixed amid supply chain challenges
Integer Holdings (NYSE:ITGR) today reported third-quarter results that beat The Street on earnings but missed on revenue amid continued supply chain challenges. The Plano, Texas–based medtech contract manufacturing giant had already warned investors early this month. It reported that deteriorating delivery performance and missed commitments from three suppliers would impact Q3 sales by $15 million. […]
Integer revises 2022 outlook amid supply chain woes
Integer (NYSE:ITGR) announced yesterday that it is revising its 2022 financial outlook due to the negative impact of the supply chain environment. Shares of ITGR took a massive hit today after yesterday’s post-market close announcement. They slid down 12.1% at $58.27 apiece in midday trading. Plano, Texas-based Integer said in a news release that its […]
Integer boosts 2022 revenue projections, cuts earnings outlook
Integer (NYSE:ITGR) posted second-quarter results today that beat the overall consensus forecast on Wall Street. The Plano, Texas–based medical device outsource manufacturer reported profits of $20.8 million, or 62¢ per share, on sales of $350 million for the three months ended July 1, for a bottom-line slide of 29.2% on sales growth of 12.2% compared with […]
Integer misses on Q1, adjusts full-year outlook
Holdings (NYSE:ITGR) posted first-quarter results today that fell short of the consensus forecast on Wall Street and adjusted its outlook for the rest of the year to include its recent acquisition of Aran Biomedical. The Plano, Texas–based medical device contract manufacturing giant reported profits of $11 million, or $0.34 per diluted share, on sales of $311 […]
Integer beats The Street in Q4
Integer Holdings (NYSE:ITGR) today reported fourth-quarter results that beat the consensus forecast on Wall Street, projecting an even better 2022 even as it works through the effects of COVID-19 omicron variant surge. The Plano, Texas–based medical device contract manufacturing giant earned $23.8 million, or 71¢ per share, off $313.0 million in sales for the quarter […]
Integer completes $220M Oscor acquisition
Integer Holdings (NYSE: ITGR) announced today that it has completed its purchase of Oscor — a deal that expands the capabilities of what was already one of the world’s largest medtech contract manufacturers. Integer said the acquisition would cost $220 million when it first announced its plans in October. Get the full story on our […]
Integer beats The Street in Q3, plans to acquire Oscor
Integer Holdings (NYSE:ITGR) posted third-quarter results today that beat the consensus forecast on Wall Street — and announced plans to spend $220 million to acquire Oscor. The Plano, Texas–based medtech contract manufacturing giant plans to finance the acquisition with debt. Integer officials expect the deal to close in December under customary closing conditions. They see […]
Integer beats The Street in Q2, boosts sales outlook
Integer Holdings (NYSE:ITGR) posted second-quarter results today that beat the consensus forecast on Wall Street — boosting its 2021 sales outlook amid continued recovery from the COVID-19 pandemic. The Plano, Texas–based medical device contract manufacturing giant reported profits of $29.4 million, or 89¢ per share, on sales of $312.0 million for the three months ended […]
Taking the guesswork out of tracking high blood pressure
Startup CoraVie Medical aims to give patients and their physicians better control over hypertension with a tiny implantable device. Aimee Garza wants to do for high blood pressure what continuous glucose monitors are doing for diabetes. The veteran medtech engineer and marketing maven brings 25 years of experience at two of medtech’s biggest companies — […]
